Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Commault Systems
CVLT
$5.79B
| $17M | 0.01% |
380,047
-77,216
| -17% | -$3.65M |
|
1327
Scansource
SCSC
$1.07B
| $17M | 0.01% |
458,827
+14,890
| +3% | +$506K |
|
1328
Gibraltar Industries
ROCK
$1.47B
| $16.9M | 0.01% |
335,594
+41,249
| +14% | +$2.07M |
|
1329
CVR Energy
CVI
$3.39B
| $16.9M | 0.01% |
418,520
-62
| -0% | -$2.73K |
|
1330
Nektar Therapeutics
NKTR
$2.53B
| $16.9M | 0.01% |
52,224
-17,771
| -25% | -$5.15M |
|
|
KAMN
1331
DELISTED
Kaman Corp
KAMN
| $16.9M | 0.01% |
255,838
+4,314
| +2% | +$269K |
|
|
CATM
1332
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $16.8M | 0.01% |
377,347
-4,788
| -1% | -$182K |
|
1333
Mueller Water Products
MWA
$4.1B
| $16.8M | 0.01% |
1,406,105
+44,549
| +3% | +$509K |
|
1334
Winnebago Industries
WGO
$928M
| $16.8M | 0.01% |
317,767
-4,111
| -1% | -$192K |
|
|
TEN
1335
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $16.8M | 0.01% |
1,284,623
+128,063
| +11% | +$1.68M |
|
|
BOLD
1336
DELISTED
Audentes Therapeutics, Inc
BOLD
| $16.8M | 0.01% |
280,904
+7,274
| +3% | +$273K |
|
1337
Quaker Houghton
KWR
$2.99B
| $16.8M | 0.01% |
101,966
+3,948
| +4% | +$612K |
|
1338
Safety Insurance
SAFT
$1.52B
| $16.8M | 0.01% |
181,139
+3,945
| +2% | +$385K |
|
1339
Cohen & Steers
CNS
$4.39B
| $16.8M | 0.01% |
266,901
+4,264
| +2% | +$270K |
|
1340
Ameris Bancorp
ABCB
$5.92B
| $16.8M | 0.01% |
393,724
+7,195
| +2% | +$307K |
|
1341
PRA Group
PRAA
$704M
| $16.7M | 0.01% |
461,163
+481
| +0.1% | +$17K |
|
1342
Adeia
ADEA
$3.06B
| $16.7M | 0.01% |
3,419,970
+127,957
| +4% | +$679K |
|
1343
NMI Holdings
NMIH
$3.37B
| $16.7M | 0.01% |
504,246
+47,719
| +10% | +$1.49M |
|
1344
Federal Signal
FSS
$7.85B
| $16.7M | 0.01% |
517,992
-39,047
| -7% | -$1.27M |
|
|
SMAR
1345
DELISTED
Smartsheet Inc.
SMAR
| $16.6M | 0.01% |
370,635
+22,562
| +6% | +$933K |
|
1346
CarGurus
CARG
$3.29B
| $16.6M | 0.01% |
472,528
+10,992
| +2% | +$389K |
|
|
WIRE
1347
DELISTED
Encore Wire Corp
WIRE
| $16.6M | 0.01% |
289,445
+6,173
| +2% | +$354K |
|
1348
NovoCure
NVCR
$2.03B
| $16.6M | 0.01% |
196,891
+3,414
| +2% | +$276K |
|
|
ECHO
1349
EchoStar
ECHO
$25.6B
| $16.6M | 0.01% |
382,475
+3,655
| +1% | +$147K |
|
1350
Axsome Therapeutics
AXSM
$11.3B
| $16.6M | 0.01% |
160,178
+7,667
| +5% | +$310K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.